China Medical System Holdings Ltd
8A8
Company Profile
Business description
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil, Salofalk, Combizym, and others.
Contact
510 King’s Road
Unit 2106, 21st Floor, Island Place Tower
North Point
Hong Kong
HKGT: +852 23697678
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
4,700
Stocks News & Analysis
stocks
AI stocks post big gains in Q3. These are the winners and losers
Alphabet and Teradyne post big gains, while Salesforce and Adobe were down in the quarter.
stocks
12 picks for an income portfolio - Q3 2025 update
Fifteen months in and passive income growth has exceeded my target.
stocks
ASX’s only dividend aristocrat reports
Cyclical headwinds persist but loan book and industrial property prop up earnings.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,280.00 | 38.90 | -0.42% |
CAC 40 | 7,971.78 | 109.76 | -1.36% |
DAX 40 | 24,378.29 | 0.51 | -0.00% |
Dow JONES (US) | 46,694.97 | 63.31 | -0.14% |
FTSE 100 | 9,479.14 | 12.11 | -0.13% |
HKSE | 26,957.77 | 183.15 | -0.67% |
NASDAQ | 22,941.67 | 161.16 | 0.71% |
Nikkei 225 | 47,944.76 | 2,175.26 | 4.75% |
NZX 50 Index | 13,489.24 | 24.85 | -0.18% |
S&P 500 | 6,740.28 | 24.49 | 0.36% |
S&P/ASX 200 | 8,981.40 | 34.80 | -0.39% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |